These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 6098495

  • 1. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M, Minor PD, Magrath DI, Schild GC.
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [Abstract] [Full Text] [Related]

  • 2. Antigenic characterization of poliovirus type 3 using monoclonal antibodies.
    Ferguson M, Minor PD, Magrath DI, Spitz M, Schild GC.
    Rev Infect Dis; 1984; 6 Suppl 2():S510-3. PubMed ID: 6204368
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA, McInnis J, Albrecht P.
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P, van der Werf S, Wychowski C, Siffert O, Girard M.
    Dev Biol Stand; 1984 Jun; 57():177-85. PubMed ID: 6084609
    [Abstract] [Full Text] [Related]

  • 11. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
    Crainic R, Blondel B, Horaud F.
    Dev Biol Stand; 1983 Jun; 55():185-9. PubMed ID: 6329856
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD, Evans DM, Ferguson M, Schild GC, Westrop G, Almond JW.
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [Abstract] [Full Text] [Related]

  • 14. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP.
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [Abstract] [Full Text] [Related]

  • 15. Antigenic sites on type 2 poliovirus.
    Patel V, Ferguson M, Minor PD.
    Virology; 1993 Jan; 192(1):361-4. PubMed ID: 7685967
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R, Blondel B, Candréa A, Dufraisse G, Horaud F.
    Dev Biol Stand; 1985 Jan; 60():343-7. PubMed ID: 2995173
    [Abstract] [Full Text] [Related]

  • 20. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R, Blondel B, Aubert-Combiescu A, Beytout D, Couillin P, Candrea A, Boué A, Horaud F.
    Dev Biol Stand; 1984 Jan; 57():165-70. PubMed ID: 6084607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.